ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Circassia pulls plug on AZ agreement pharmatimes
April 10, 2020Circassia Pharmaceuticals is pulling back from its development and commercialisation agreement with AstraZeneca for US commercial rights to COPD therapies Tudorza (aclidinium) and Duaklir (aclidinium/formoterol).
Pharma Sources Insight January 2025
